Amicus Therapeutics, Inc. reported raising $200 Million in an initial SEC Form D filing, from an offering of $200 Million
TAKEN PRIVATEOct 13, 2021
Amount Raised
$200 Million
$200 Million sold, per SEC Form D (first sale Oct 13, 2021)
Round Type
Venture
PrincetonBiotechnologyHealth CareTherapeuticsWho to call at Amicus Therapeutics, and when
A new round usually means Amicus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amicus Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amicus Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amicus Therapeutics. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amicus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
1 contact
Amicus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.